| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-11 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-09 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-08 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-07 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-06 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |